Active Studies

Deficits in both the peripheral and central nervous systems are important complications found in people with Type 2 diabetes (T2D). Conditions such diabetic peripheral neuropathy (DPN) and slowing of the neural signals in the brain have been described in subjects with DM2, which are consistent with motor control and cognitive impairments observed in this population. A good cognitive and motor control is essential for manual function and dexterity such as drinking from a glass, buttoning a shirt, and, in case of people with diabetes, checking blood glucose levels or giving self-injections.

The main objective of this research project is to investigate the cognitive effort, measured by pupil dilation, during dual tasking and its accurate prediction of falls in Parkinson's disease 

Compensation will be available for your participation in the study.

Changes in cognitive functions are commonly seen in healthy aging. These changes are usually benign as they will not seriously hinder the ability to perform activities of daily living. However, older adults have a higher risk of developing cognitive impairments. A prevalent condition that affect cognitive functions in older adults is Alzheimer's disease.

The purpose of this study is to learn if cognitive behavioral therapy for insomnia (CBT-I)
will improve sleep quality, fatigue, and quality of life in individuals with multiple
sclerosis (MS) with symptoms of insomnia.

In this trial, the objectives are to determine the efficacy and toxicity of induction
chemotherapy (IC) with nab-paclitaxel + cisplatin (Arm 1: AP) and with nab-paclitaxel (Arm
2: A) alone in patients with HNSCC, and to compare these data to nab-paclitaxel, cisplatin,
and 5-FU (APF). The investigators also hypothesize that the high anti-tumor efficacy of
nab-paclitaxel in HNSCC is due to the upregulation of macropinocytosis, a result of the
frequent presence of Ras and PI3K (and epidermal growth factor receptor -EGFR) activation in
this cancer.